Galaxy Visions Group

Retail outlook said worst since early 1990s

LONDON (Reuters) - The next 12 months are likely to be the slowest period for Britain’s retailers since the early 1990s, researchers Experian said on Friday.

…

Read the original:
Retail outlook said worst since early 1990s

U.S. economy fears plague stocks but buoy bonds

HONG KONG (Reuters) - Asian investors balked at ugly U.S. economic data and a grim outlook for Japanese banks, causing stocks to sag and safe-haven bonds to perk up on Friday, …

See more here:
U.S. economy fears plague stocks but buoy bonds

Outcry expected at Yahoo meeting

SAN FRANCISCO (Reuters) - Yahoo’s annual investor meeting on Friday will be a magnet for discontent over the company’s failure to reach a merger deal with Microsoft and complaints about the company’s past performance.

Read the original here:
Outcry expected at Yahoo meeting

GFI Group 2nd-qtr profit jumps

(Reuters) - Inter-dealer broker GFI Group , which earlier confirmed that it was in merger talks with rival Tullett Prebon , said quarterly profit rose 24 percent, helped by higher brokerage revenue.

Here is the original post:
GFI Group 2nd-qtr profit jumps

Biogen and Elan report Tysabri brain disease cases

LOS ANGELES/NEW YORK (Reuters) - Biogen Idec and Elan have notified regulators of two new cases of a potentially deadly brain disease in multiple sclerosis (MS) patients being treated with Tysabri.

See original here:
Biogen and Elan report Tysabri brain disease cases

Retail outlook worst since early 1990s

LONDON (Reuters) - The next 12 months are likely to be the slowest period for retailers since the early 1990s, researchers Experian said on Friday.

Go here to see the original:
Retail outlook worst since early 1990s

Bristol offers to buy ImClone

NEW YORK (Reuters) - Bristol-Myers Squibb has offered to buy ImClone Systems Inc for $60 a share, valuing its biotech partner at $5.2 billion (2.6 billion pounds) in a deal to strengthen its grip on the fast-growing Erbitux cancer drug.

Credit:
Bristol offers to buy ImClone

Oil company profits soar

LONDON/NEW YORK (Reuters) - Exxon Mobil broke its own record for the highest-ever quarterly profit for a U.S. company on Thursday, joining other major oil companies in posting stronger earnings on the back of …

Continued here:
Oil company profits soar

Bristol offers to buy ImClone for $60 a share

NEW YORK (Reuters) - Bristol-Myers Squibb Co has offered to buy ImClone Systems Inc for $60 a share, valuing its biotech partner at $5.2 billion (2.6 billion pounds) in a deal to strengthen its grip on the fast-growing Erbitux cancer drug.

Here is the original:
Bristol offers to buy ImClone for $60 a share

British hedge fund invests in WaMu and Sovereign

NEW YORK (Reuters) - An activist British hedge fund has taken a 6 percent stake in Washington Mutual as the largest U.S. savings and loan tries to rebound from billions of dollars of mortgage-related losses.

Read more here:
British hedge fund invests in WaMu and Sovereign